A federal judge on Monday dismissed antitrust litigation accusing pharmaceutical company AbbVie of illegally shielding its blockbuster arthritis drug Humira from cheaper biosimilar versions using a “thicket” of patents.
U.S District Judge Manish Shah of the Northern District of Illinois said the plaintiffs, all indirect purchasers of the drug, failed to allege that the Chicago-based company violated federal or state antitrust laws through its use of the legal patent process.
To read the full story on Westlaw Practitioner Insights, click here: bit.ly/3f0vAZt
